Peptide Stacking: Combinations, Logic, and Limits

A GHRH analog (CJC-1295, sermorelin) combined with a ghrelin agonist (ipamorelin) acts on two distinct pituitary pathways, producing a larger GH pulse than either alone. This synergy is mechanistically documented.

BPC-157 with TB-500 for injury recovery is popular but rests on separate animal datasets with no combination trials.

Adding multiple novel peptides at once makes attribution impossible: if something works or something goes wrong, you cannot tell which agent caused it.

Introduce one new peptide at a time and hold it for at least two weeks before adding another.

Do not stack two agents with the same mechanism — two ghrelin agonists add side effects, not effect.

Keep a written log of dose, timing, and response. The Progress Tracker exists for exactly this.